Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2/3 1Phase 2 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5Other 1Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Lymphoma, Follicular 1067Lymphoma, Large B-Cell, Diffuse 1060Hodgkin Disease 906Leukemia 877Lymphoma, Mantle-Cell 738Leukemia, Myeloid, Acute 662Burkitt Lymphoma 604Multiple Myeloma 556Lymphoma, B-Cell, Marginal Zone 546Myelodysplastic Syndromes 507Recurrence 451Lymphoma, B-Cell 415Lymphoma, Large-Cell, Immunoblastic 328Waldenstrom Macroglobulinemia 323Lymphoma, T-Cell, Cutaneous 322Mycosis Fungoides 277Neoplasms 257Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Myeloproliferative Disorders 249Neoplasms, Plasma Cell 242Sezary Syndrome 231Leukemia, Myelogenous, Chronic, BCR-ABL Positive 221Lymphoma, Large-Cell, Anaplastic 215Leukemia, Myeloid, Accelerated Phase 211Lymphoma, T-Cell, Peripheral 205Blast Crisis 203

Interventions

Ultrasonic Waves 1Tirzepatide 1Therapeutics 1Standard of Care 1Educational Status 1Dosage Forms 1Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Opioid-Related Disorders × Lymphoid × Clear all
NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting
310 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT07451197 2026-05-11

Family-Focused Study to Support Medication for Opioid Use Disorder

University of Wisconsin, Madison

Phase NA Not yet recruiting
338 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT04091009 2025-12-31

Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Massachusetts General Hospital

Phase 4 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04345718 2025-12-09

EXHITENTRE

Hennepin Healthcare Research Institute

Phase 2/3 Completed
344 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡